Avanos Medical (AVNS) Cash from Operations (2013 - 2026)

Avanos Medical's Cash from Operations history runs 14 years deep, the most recent figure standing at 12300000.0 for Q1 2026.

• In Q1 2026, Cash from Operations fell 147.86% year-over-year to 12300000.0; the TTM figure through Mar 2026 stood at 36700000.0 (down 72.69% YoY), while the FY2025 annual figure was 74700000.0, down 25.82% from the prior year.
• Cash from Operations came in at 12300000.0 for Q1 2026 at Avanos Medical, down from 28200000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 57900000.0 in Q4 2024 to a low of 12300000.0 in Q1 2026.
• A 5-year average of 16847058.82 and a median of 23000000.0 in 2024 frame the typical range for Cash from Operations.
• Across the five-year window, Cash from Operations tumbled 477.78% in 2023 and soared 1169.23% in 2024, its largest moves.
• Avanos Medical's Cash from Operations stood at 33700000.0 in 2022, then plunged by 62.31% to 12700000.0 in 2023, then soared by 355.91% to 57900000.0 in 2024, then tumbled by 51.3% to 28200000.0 in 2025, then sank by 143.62% to 12300000.0 in 2026.
• According to Business Quant data, Cash from Operations over the past three periods registered 12300000.0, 28200000.0, and 14000000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison